Japan health minister to consider U.S. drug firms’ views in pricing overhaul

TOKYO (Reuters) – Japan will weigh the concerns of U.S. drug firms in its efforts to complete by year-end a drastic revision of its drug-pricing system, aimed at reining in medical spending and cutting the public burden, the health minister said on Friday.


Reuters: Health News

Leave a Reply